Economic and humanistic burden in kidney transplant rejection: a literature review

References

• Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2017 annual data report: kidney. Am J Transplant. 2019 Feb;19 Suppl 2:19–123.
   PubMed Web of Science ®Google Scholar
• Loupy A, Haas M, Roufosse C, et al. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant. 2020;20(9):2318–2331. doi: 10.1111/ajt.15898
   PubMed Web of Science ®Google Scholar
• Schinstock CA, Mannon RB, Budde K, et al. Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantation society working group. Transplantation. 2020;104(5):911–922. doi: 10.1097/TP.0000000000003095
   PubMed Web of Science ®Google Scholar
• Ho J, Okoli GN, Rabbani R, et al. Effectiveness of T cell-mediated rejection therapy: a systematic review and meta-analysis. Am J Transplant. 2022;22(3):772–785. doi: 10.1111/ajt.16907
   PubMed Web of Science ®Google Scholar
• Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant. 2009;9(11):2520–2531. doi: 10.1111/j.1600-6143.2009.02799.x
   PubMed Web of Science ®Google Scholar
• Augustine T, Gill J, Budde K, et al. International, matched-cohort checkerboard study of quality of life and disease burden in kidney transplant (TX) patients with antibody-mediated rejection (AMR). Transplant Int. 2019;32:310.
   Google Scholar
• Banga R, Schinstock C, Boscoe A, et al. Burden of early antibody-mediated rejection (AMR): complications, resource utilization and cost-differential in treatment of AMR. Am J Transplant. 2015;15(Suppl 3):A296.
   Google Scholar
• Hart A, Zaun D, Itzler R, et al. Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US. J Med Econ. 2021;24(1):1011–1017. doi: 10.1080/13696998.2021.1964267
   PubMed Web of Science ®Google Scholar
• Irish W, Boscoe A, Ryan M, et al. Economic burden of antibody mediated rejection following kidney transplantation: comparative analysis using the Premier hospital database. Value Health. 2015;18(3):A187. doi: 10.1016/j.jval.2015.03.1082
   Web of Science ®Google Scholar
• Kulkarni S, Hall I. Association of de novo antibody-mediated rejection and increased hospital costs following kidney transplant in immunologically low-risk patients. Am J Transplant. 2015;15(Suppl 3): A127.
   Google Scholar
• McDermott C, Carsky K, Ferrin P, et al. Analysis of cost effectiveness of treatment for acute antibody-mediated rejection. Am J Transplant. 2018;18:734.
   Web of Science ®Google Scholar
• Muduma G, Odeyemi I, Pollock RF. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK. J Med Econ. 2015;18(12):1050–1059. doi: 10.3111/13696998.2015.1074584
   PubMed Web of Science ®Google Scholar
• Muduma G, Odeyemi IA, Pollock RF. Evaluating the economic implications of nonadherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily, prolonged-release tacrolimus in the UK setting. Value Health. 2015;18(3):A187. doi: 10.1016/j.jval.2015.03.1081
   Web of Science ®Google Scholar
• Vo AA, Petrozzino J, Yeung K, et al. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation. 2013;95(6):852–858. doi: 10.1097/TP.0b013e3182802f88
   PubMed Web of Science ®Google Scholar
• Hart A, Singh D, Brown SJ, et al. Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: a systematic review. Clin Transplant. 2021;35(7):e14320. doi: 10.1111/ctr.14320
   PubMed Web of Science ®Google Scholar
• Gheorghian A, MA S, DA A, et al. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation. 2012;94(3):241–249. doi: 10.1097/TP.0b013e318255f839
   PubMed Web of Science ®Google Scholar
• Kim M, Martin ST, Townsend KR, et al. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. Pharmacotherapy. 2014;34(7):733–744. doi: 10.1002/phar.1426
   PubMed Web of Science ®Google Scholar
• Schnitzler MA, Johnston K, Axelrod D, et al. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation. 2011;91(12):1347–1356. doi: 10.1097/TP.0b013e31821ab993
   PubMed Web of Science ®Google Scholar
• Sussell J, Silverstein AR, Goutam P, et al. The economic burden of kidney graft failure in the United States. Am J Transplant. 2020;20(5):1323–1333. doi: 10.1111/ajt.15750
   PubMed Web of Science ®Google Scholar
• Julián-Mauro JC, Cuervo J, Rebollo P, et al. Employment status and indirect costs in patients with renal failure: differences between different modalities of renal replacement therapy. Nefrologia. 2013;33(3):333–341. doi: 10.3265/Nefrologia.pre2012.Dec.11767
   PubMed Web of Science ®Google Scholar
• Calia R, Lai C, Aceto P, et al. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. Transplant Proc. 2011;43(4):1020–1023. doi: 10.1016/j.transproceed.2011.03.048
   PubMed Web of Science ®Google Scholar
• Gibbons A, Bayfield J, Cinnirella M, et al. Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews. BMJ Open. 2021;11(4):e047263. doi: 10.1136/bmjopen-2020-047263
   PubMed Web of Science ®Google Scholar
• Gibbons A, Bradley C. The effects of kidney alone or simultaneous pancreas and kidney transplant on quality of life and health status: findings from ATTOM programme cohorts with baseline data. Nephrol Dial Transplant. 2016;31(suppl_1):i450. doi: 10.1093/ndt/gfw189.33
   Google Scholar
• Kochar GS, Rega SA, Feurer ID, et al. Association of kidney function with patient reported outcomes after kidney transplantation. Am J Transplant. 2021;21(Suppl 4):667.
   Google Scholar
• Neri L, McEwan P, Sennfält K, et al. Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study. Health Qual Life Outcomes. 2012;10(1):139. doi: 10.1186/1477-7525-10-139
   PubMedGoogle Scholar
• Neri L, Dukes J, Brennan DC, et al. Impaired renal function is associated with worse self-reported outcomes after kidney transplantation. Qual Life Res. 2011;20(10):1689–1698. doi: 10.1007/s11136-011-9905-8
   PubMed Web of Science ®Google Scholar
• Perl J, Zhang J, Gillespie B, et al. Reduced survival and quality of life following return to dialysis after transplant failure: the dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2012;27(12):4464–4472. doi: 10.1093/ndt/gfs386
   PubMed Web of Science ®Google Scholar
• Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation. 2018;102(11):1795–1814. doi: 10.1097/TP.0000000000002366
   PubMed Web of Science ®Google Scholar
• Moore K. New diagnosis codes effective Oct. 1. Here are some family physicians should know. American Academy of Family Physicians: FPM journal [Internet]. 2021 Aug 1 [cited 12 Aug 2022]; Getting Paid, A Blog from FPM Journal. Available from: https://www.aafp.org/journals/fpm/blogs/gettingpaid/entry/new_diagnosis_codes.html
   Google Scholar
• Family Heart Foundation. The ICD-10 codes for familial hypercholesterolemia are approved! Family heart foundation [Internet]. 2016 Jun 30 [cited 14 Apr 2022]; ICD-10 Code Approved. Available from: https://thefhfoundation.org/the-icd-10-codes-for-familial-hypercholesterolemia-are-approved
   Google Scholar